Alliance Pharma (APH)

 

Latest News

Changes to interests of a significant shareholder

RNS Number: 1266D Alliance Pharma PLC 24 April 2017 For immediate release 24 April 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In acco...

Notification of Major Interest in Shares

RNS Number: 6866B Alliance Pharma PLC 05 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Alliance Pharma plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisitio...

Application for admission

RNS Number: 2497B Alliance Pharma PLC 31 March 2017 For immediate release 31 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a...

Full Year Results

RNS Number: 8463A Alliance Pharma PLC 29 March 2017 29 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Results for the year ended 31 December 2016 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its results for the year ended 31 December 2016. Financial Highlights Revenue up 102% at 97.5m...

All News

DateHeadlineSource
24-04-17Changes to interests of a significant shareholderRNS
05-04-17Notification of Major Interest in SharesRNS
31-03-17Application for admissionRNS
29-03-17Full Year ResultsRNS
21-03-17Alliance Pharma settlement agreement with SinclairStockMarketWire
21-03-17Settlement Agreement with Sinclair Pharma plcRNS
02-03-17Alliance Pharma schedules FY results StockMarketWire
02-03-17Notification of Preliminary ResultsRNS
14-02-17Director Deals - Alliance Pharma PLC (APH)StockMarketWire
14-02-17Director Deals - Alliance Pharma PLC (APH)StockMarketWire
14-02-17PDMR shareholdingRNS
14-02-17Application for admissionRNS
07-02-17Changes to interests of a significant shareholderRNS
31-01-17Exercise of Share OptionsRNS
25-01-17Hardman Research: Potential of DiclectinRNS
23-01-17Alliance revenues more than double StockMarketWire
23-01-17Pre-Close Trading UpdateRNS
16-12-16Exercise of Share OptionsRNS
16-12-16Alliance Pharma options exercised StockMarketWire
15-12-16Exercise of Share OptionsRNS
12-12-16Alliance Pharma options exercised StockMarketWire
12-12-16Exercise of Share OptionsRNS
09-12-16TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESRNS
08-12-16Alliance to host capital markets day StockMarketWire
08-12-16Capital Markets EventRNS
30-11-16Notification of Major Interest in SharesRNS
24-11-16Alliance Pharma options exercised StockMarketWire
23-11-16Exercise of Share OptionsRNS
28-10-16Share OptionsRNS
28-10-16Alliance Pharma appoints deputy CEO StockMarketWire
28-10-16Appointment of Deputy CEORNS
06-10-16Alliance Pharma options exercised StockMarketWire
05-10-16Exercise of Share OptionsRNS
23-09-16Director Deals - Alliance Pharma PLC (APH)StockMarketWire
23-09-16Exercise of Share OptionsRNS
23-09-16Director DealingsRNS
14-09-16Are these 2 healthcare stocks ‘screaming buys’?Motley Fool
14-09-16Alliance revenues up 104%StockMarketWire
14-09-16Interim ResultsRNS
13-09-16New Agreement for Diclectin in EuropeRNS

RSS feeds

  • Editorial news feed for LSE:APH Editorial
  • Regulatory news feed for LSE:APH Regulatory